반응식
C(C1N=C(N2CCOCC2)C2N=NN(CC3C=CC=CC=3Cl)C=2N=1)(C)(C)C.[C:28]([C:32]1[N:33]=[C:34](Cl)[C:35]2[N:40]=[N:39][N:38]([CH2:41][C:42]3[CH:47]=[CH:46][CH:45]=[CH:44][C:43]=3[Cl:48])[C:36]=2[N:37]=1)([CH3:31])([CH3:30])[CH3:29].[CH3:50][C@@H:51]1[CH2:55][CH2:54][C@@H:53]([CH3:56])[NH:52]1>>[C:28]([C:32]1[N:33]=[C:34]([N:52]2[C@H:53]([CH3:56])[CH2:54][CH2:55][C@H:51]2[CH3:50])[C:35]2[N:40]=[N:39][N:38]([CH2:41][C:42]3[CH:47]=[CH:46][CH:45]=[CH:44][C:43]=3[Cl:48])[C:36]=2[N:37]=1)([CH3:31])([CH3:30])[CH3:29]참가 물질
4
반응물 3
생성물 1
실험 절차
In analogy to the procedure described for the synthesis of 5-tert-butyl-3-(2-chloro-benzyl)-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidine (example 1, step c), the title compound was prepared from 5-tert-butyl-7-chloro-3-(2-chlorobenzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine and (2R,5R)-2,5-dimethylpyrrolidine and isolated as colorless gum (11.2 mg, 60%). MS (m/e): 399.4 (MH+).
출처 및 근거
- ORD 기록
- ord-f439db30c24249048f6b545f77cc710d
- 출처 데이터셋
- uspto-grants-2014_06
- 특허 번호
- US08741906B2
연결된 노트
불러오는 중…